Jessica B. Langbaum

7.2k citations

109 papers · 3.8k indexed · 1 hit paper · h-index 31

Co-authors: Eric M. Reiman Kewei Chen Pierre N. Tariot Adam Fleisher Richard J. Caselli Napatkamon Ayutyanont Wendy Lee Gene E. Alexander
Topics: Dementia and Cognitive Impairment Research (59 papers)Alzheimer's disease research and treatments (38 papers)Health Systems, Economic Evaluations, Quality of Life (14 papers)
Cited by: Psychiatry and Mental health Physiology Neuropsychology and Physiological Psychology
Journals: Proceedings of the National Academy of Sciences PLoS ONE NeuroImage
Partner nations: United States Colombia Switzerland

In The Last Decade

Jessica B. Langbaum

98 papers receiving 3.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Fibrillar amyloid-β burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease

2009 618 citations Eric M. Reiman, Kewei Chen et al. Proceedings of the National Academy of Sciences profile →

Peers

Countries citing papers authored by Jessica B. Langbaum

Since Specialization

Citations

This map shows the geographic impact of Jessica B. Langbaum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jessica B. Langbaum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jessica B. Langbaum more than expected).

Fields of papers citing papers by Jessica B. Langbaum

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jessica B. Langbaum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jessica B. Langbaum. The network helps show where Jessica B. Langbaum may publish in the future.

Co-authorship network of co-authors of Jessica B. Langbaum

This figure shows the co-authorship network connecting the top 25 collaborators of Jessica B. Langbaum. A scholar is included among the top collaborators of Jessica B. Langbaum based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jessica B. Langbaum. Jessica B. Langbaum is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	What is older adults’ understanding of Alzheimer's disease research registries? Findings from 20 focus group studies 2025 ·Alzheimer s & Dementia Translational Research & Clinical Interventions ·(unknown),(unknown),Erin K. Maloney,Jessica B. Langbaum,Amy Bleakley	1
2	Impact of learning APOE genotype on cognitively unimpaired adults: a pre-screening cohort study of the Alzheimer’s Prevention Initiative Generation Study 1 2025 ·The Lancet Healthy Longevity ·Jessica B. Langbaum,Angela R. Bradbury,Brian L. Egleston,Elisabeth McCarty Wood,Carolyn Langlois,Emily A. Largent,Kristin Harkins,(unknown),Shana D. Stites,(unknown),Marie‐Emmanuelle Riviere,Fonda Liu,Ana Graf,Scott Y. H. Kim,Joshua D. Grill,Eric M. Reiman,Pierre N. Tariot,J. Scott Roberts,Jason Karlawish	0
3	Donanemab in preclinical Alzheimer's disease: Screening and baseline data from TRAILBLAZER‐ALZ 3 2025 ·Alzheimer s & Dementia ·R. Yaari,Karen C. Holdridge,(unknown),Alette M. Wessels,Sergey Shcherbinin,(unknown),(unknown),Pierre N. Tariot,Robert Alexander,Jessica B. Langbaum,John R. Sims	4
4	Study Design of the Evaluation of Self‐Mediated Alternatives for Risk Testing Education and Return of Results ‐ E‐SMARTER: A randomized trial from the Alzheimer’s Prevention Initiative program 2024 ·Alzheimer s & Dementia ·Carolyn Langlois,Angela R. Bradbury,(unknown),Kristin Harkins,(unknown),Emily A. Largent,Brian L. Egleston,Eric M. Reiman,Joshua D. Grill,J. Scott Roberts,Jason Karlawish,Jessica B. Langbaum	0
5	Theory-Based Message Design for Recruitment of Underrepresented Racial/Ethnic Groups Into Alzheimer’s-Focused Research Registries 2024 ·Health Education & Behavior ·Amy Bleakley,Erin K. Maloney,Michael Hennessy,Shawnika J. Hull,Kristin Harkins,Emily A. Largent,Miriam T. Ashford,(unknown),DeAnnah R. Byrd,Rachel L. Nosheny,Jason Karlawish,Jessica B. Langbaum	2
6	Reversibility of cognitive worsening observed with BACE inhibitor umibecestat in the Alzheimer's Prevention Initiative (API) Generation Studies 2024 ·Alzheimer s & Dementia ·Pierre N. Tariot,Marie‐Emmanuelle Riviere,Stephen Salloway,Jeffrey M. Burns,Jón Snædal,Beth Borowsky,(unknown),Fonda Liu,Marie‐Laure Rouzade‐Dominguez,Pilar Cazorla,(unknown),Michał Arkuszewski,(unknown),Vissia Viglietta,(unknown),Angelika Caputo,Jessica B. Langbaum,(unknown),Ana Graf	6
7	Effects of the active amyloid beta immunotherapy CAD106 on PET measurements of amyloid plaque deposition in cognitively unimpaired APOE ε4 homozygotes 2023 ·Alzheimer s & Dementia ·Marie‐Emmanuelle Riviere,Jessica B. Langbaum,Raymond Scott Turner,Juha O. Rinne,(unknown),Pilar Cazorla,(unknown),(unknown),Angelika Caputo,Pierre N. Tariot,Eric M. Reiman,Ana Graf	18
8	Statistical innovations in the API ADAD Colombia trial: a randomized, double‐blind, placebo‐controlled, parallel‐group study in cognitively unimpaired PSEN1 E280A mutation carriers evaluating efficacy and safety of crenezumab 2023 ·Alzheimer s & Dementia ·Nan Hu,Howard Mackey,Rachelle S. Doody,Francisco Lopera,Pierre N. Tariot,Eric M. Reiman,Ronald G. Thomas,Jessica B. Langbaum,Kaycee M. Sink	0
9	The politics of mask-wearing: Political preferences, reactance, and conflict aversion during COVID 2022 ·Social Science & Medicine ·Dannagal G. Young,(unknown),Amy Bleakley,Jessica B. Langbaum	37
10	“I feel it in my gut:” Epistemic motivations, political beliefs, and misperceptions of COVID-19 and the 2020 U.S. presidential election 2022 ·Journal of Social and Political Psychology ·Dannagal G. Young,Erin K. Maloney,Amy Bleakley,Jessica B. Langbaum	10
11	Early Stages of Alzheimer's Disease: Evolving the Care Team for Optimal Patient Management 2021 ·Frontiers in Neurology ·James E. Galvin,Paul Aisen,Jessica B. Langbaum,Eric Rodríguez,Marwan N. Sabbagh,Richard G. Stefanacci,Robert A. Stern,(unknown),Arno de Wilde,Neva West,Ivana Rubino	34
12	The Generation program: Baseline characteristics of cognitively unimpaired APOE4 carriers recruited for Generation study 1 and Generation study 2 2020 ·Alzheimer s & Dementia ·Pierre N. Tariot,Beth Borowsky,Fonda Liu,Marie‐Emmanuelle Riviere,Marie‐Laure Rouzade‐Dominguez,Pilar Cazorla,(unknown),(unknown),Jessica B. Langbaum,Vissia Viglietta,(unknown),Angelika Caputo,Eric M. Reiman,Ana Graf	2
13	The Value of Pre-Screening in the Alzheimer's Prevention Initiative (API) Autosomal Dominant Alzheimer's Disease Trial 2018 ·The Journal of Prevention of Alzheimer s Disease ·Silvia Ríos‐Romenets,(unknown),Hender López,(unknown),Cláudia Ramos,Natalia Acosta‐Baena,Claudia Muñoz,(unknown),Carlos Tobón,Woohyun Cho,Michael E. Ward,Jessica B. Langbaum,Pierre N. Tariot,Eric M. Reiman,Francisco Lopera	4
14	Blood pressure is associated with higher brain amyloid burden and lower glucose metabolism in healthy late middle-age persons 2011 ·Neurobiology of Aging ·Jessica B. Langbaum,Kewei Chen,Lenore J. Launer,Adam Fleisher,Wendy Lee,Xiaofen Liu,Hillary Protas,Stephanie Reeder,Daniel Bandy,Meixiang Yu,Richard J. Caselli,Eric M. Reiman	103
15	Characterizing Alzheimer's disease using a hypometabolic convergence index 2011 ·NeuroImage ·Kewei Chen,Napatkamon Ayutyanont,Jessica B. Langbaum,Adam Fleisher,Cole Reschke,Wendy Lee,Xiaofen Liu,Dan Bandy,Gene E. Alexander,Paul M. Thompson,Leslie M. Shaw,John Q. Trojanowski,Clifford R. Jack,Susan Landau,Norman L. Foster,Danielle Harvey,Michael W. Weiner,Robert A. Koeppe,William J. Jagust,Eric M. Reiman	123
16	Assessing the reliability to detect cerebral hypometabolism in probable Alzheimer's disease and amnestic mild cognitive impairment 2010 ·Journal of Neuroscience Methods ·Xia Wu,Kewei Chen,Li Yao,Napatkamon Ayutyanont,Jessica B. Langbaum,Adam Fleisher,Cole Reschke,Wendy Lee,Xiaofen Liu,Gene E. Alexander,Dan Bandy,Norman L. Foster,Paul M. Thompson,Danielle Harvey,Michael W. Weiner,Robert A. Koeppe,William Jagust,Eric M. Reiman	13
17	Hypometabolism in Alzheimer-Affected Brain Regions in Cognitively Healthy Latino Individuals Carrying the Apolipoprotein E ε4 Allele 2010 ·Archives of Neurology ·Jessica B. Langbaum,Kewei Chen,Richard J. Caselli,Wendy Lee,Cole Reschke,Daniel Bandy,Gene E. Alexander,Christine Burns,Alfred W. Kaszniak,Stephanie Reeder,Jason J. Corneveaux,April N. Allen,Jeremy J. Pruzin,Matthew J. Huentelman,Adam Fleisher,Eric M. Reiman	81
18	Twelve-month metabolic declines in probable Alzheimer's disease and amnestic mild cognitive impairment assessed using an empirically pre-defined statistical region-of-interest: Findings from the Alzheimer's Disease Neuroimaging Initiative 2010 ·NeuroImage ·Kewei Chen,Jessica B. Langbaum,Adam Fleisher,Napatkamon Ayutyanont,Cole Reschke,Wendy Lee,Xiaofen Liu,Dan Bandy,Gene E. Alexander,Paul M. Thompson,Norman L. Foster,Danielle Harvey,Mony J. de Leon,Robert A. Koeppe,William Jagust,Michael W. Weiner,Eric M. Reiman	121
19	Association between GAB2 haplotype and higher glucose metabolism in Alzheimer's disease-affected brain regions in cognitively normal APOEε4 carriers 2010 ·NeuroImage ·Winnie S. Liang,Kewei Chen,Wendy Lee,(unknown),Jason J. Corneveaux,April N. Allen,Amanda Myers,Stephen Villa,Bessie Meechoovet,Jeremy J. Pruzin,Daniel Bandy,Adam Fleisher,Jessica B. Langbaum,Matthew J. Huentelman,Kendall Jensen,Travis Dunckley,Richard J. Caselli,(unknown),Eric M. Reiman	16
20	Fibrillar amyloid-β burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's diseasebreakdown → 2009 ·Proceedings of the National Academy of Sciences ·Eric M. Reiman,Kewei Chen,Xiaofen Liu,Daniel Bandy,Meixiang Yu,Wendy Lee,Napatkamon Ayutyanont,Jennifer Keppler,Stephanie Reeder,Jessica B. Langbaum,Gene E. Alexander,William E. Klunk,Chester A. Mathis,Julie C. Price,Howard Aizenstein,Steven T. DeKosky,Richard J. Caselli	618

About Jessica B. Langbaum

Jessica B. Langbaum is a scholar working on Psychiatry and Mental health, Physiology and Geriatrics and Gerontology, having authored 109 papers that have together received 3.8k indexed citations. Recurring topics across this work include Dementia and Cognitive Impairment Research (59 papers), Alzheimer's disease research and treatments (38 papers) and Health Systems, Economic Evaluations, Quality of Life (14 papers). The work is most often cited by research in Psychiatry and Mental health (2.1k citations), Physiology (2.0k citations) and Neuropsychology and Physiological Psychology (95 citations). Jessica B. Langbaum has collaborated with scholars based in United States, Colombia and Switzerland. Frequent co-authors include Eric M. Reiman, Kewei Chen, Pierre N. Tariot, Adam Fleisher, Richard J. Caselli, Napatkamon Ayutyanont, Wendy Lee, Gene E. Alexander, George W. Rebok and Michelle C. Carlson. Their work appears in journals such as Proceedings of the National Academy of Sciences, PLoS ONE and NeuroImage.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact